Globe Newswire » trang 132 » Trang Công Nghệ | Trangcongnghe.vn

onsemi Introduces Industry-First Elite Pairing Studio to Simplify Power Design

onsemi Introduces Industry-First Elite Pairing Studio to Simplify Power Design

Globenewswire -

Update on the simplified tender offer for North Atlantic Energies shares

Update on the simplified tender offer for North Atlantic Energies shares

Globenewswire -

Copenhagen Infrastructure Partners partially divests 500MW Devilla BESS project to Scottish National Investment Bank and Nuclear Liabilities Fund

Copenhagen Infrastructure Partners partially divests 500MW Devilla BESS project to Scottish National Investment Bank and Nuclear Liabilities Fund

Globenewswire -

Digital Realty Launches Malaysia Operations to Advance Southeast Asia’s Digital Connectivity

Digital Realty Launches Malaysia Operations to Advance Southeast Asia’s Digital Connectivity

Globenewswire -

Boehringer Ingelheim’s survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting improved metabolic health in people living with obesity

Boehringer Ingelheim’s survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting improved metabolic health in people living with obesity

Globenewswire -

Yuno Provides Corporate Update as It Advances Toward Launch, Expands Leadership Team with Talent from Binance, and Positions for Global Prediction Market Growth

Yuno Provides Corporate Update as It Advances Toward Launch, Expands Leadership Team with Talent from Binance, and Positions for Global Prediction Market Growth

Globenewswire -

Teva Presents New Data on AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets that Show Patient- and Caregiver-Reported Improvements in Huntington's Disease Chorea

Teva Presents New Data on AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets that Show Patient- and Caregiver-Reported Improvements in Huntington's Disease Chorea

Globenewswire -

XEM THÊM TIN MỚI